Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 18, 2020 / 04:25PM GMT
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Hey, everybody. Welcome to a great session here at the Jefferies virtual London healthcare conference. I am virtually here in London as evidenced by my background there. And my good friends at Moderna CEO, Stéphane Bancel; and Lavina Talukdar, who heads up IR here with me, probably, in Boston or wherever they're at. But great to have you with us. We also may be joined by CFO, David Meline, to talk about revenues as well, which is always an important topic for the audience. So when he's here, we'll bring him in.

Well, first of all, I mean, I just wanted to start off, Stéphane. Congrats on everything to date. I think everyone is hugely proud and happy with the results recently and really happy with all the execution.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

I just wanted to start off by asking from a high level to talk about the profile of your vaccine. And I don't want to get into differentiation thing, but just talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot